Instil Bio Inc.

NASDAQ: TIL · Real-Time Price · USD
28.00
-0.25 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
27.84
-0.57%
After-hours: Aug 15, 2025, 04:14 PM EDT

Instil Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 3.99M n/a n/a n/a 7.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
12K 498K 1.99M 900K 1M 993K 1.04M 953K 835K 2.05M 807K 2.4M 979K 1.8M 893K 764K 656K 439K
Gross Profit
-12K -498K 1.99M -900K -1M -993K 6.63M -953K -835K -2.05M -807K -2.4M -979K -1.8M -893K -764K -656K -439K
Operating Income
-12.9M -30.56M -16.6M -23.63M -13.63M -19.68M 55.61M -66.72M -20.99M -58.45M -56.8M -56.65M -58.72M -54.29M -53.75M -43.02M -35.38M -23.4M
Interest Income
1.04M 1.18M 1.35M 1.65M 1.92M 2.06M 2.19M 2.31M 2.29M 2.07M 1.8M 1.28M 486K 97K n/a 22K 15K n/a
Pretax Income
-21.39M -28.2M -11.89M -23.02M -14.92M -24.3M -12.93M -67.43M -18.66M -57.07M -54.45M -56.59M -59.6M -54.6M -54.29M -43.66M -35.47M -23.33M
Net Income
-21.39M -28.2M -11.89M -23.02M -14.92M -24.3M -12.93M -67.43M -18.66M -56.33M -53.84M -56.22M -58.99M -54.12M -55.35M -43.01M -35.31M -23.13M
Selling & General & Admin
6.14M 9.11M 11.37M 10.71M 10.71M 11.43M 9.84M 11.94M 11.52M 13.22M 12.91M 16.99M 17.22M 15.11M 11.18M 13.96M 14.2M 8.98M
Research & Development
6.74M 5.37M 1.1M 10M 2.92M 7.26M 1.98M 8.49M 8.46M 20.67M 20.72M 39.66M 41.5M 39.17M 42.58M 29.06M 21.19M 14.42M
Other Expenses
n/a -498K -1.73M 2.92M -1M n/a n/a -953K 628K -57K 1.3M -415K -1.03M -319K -538K n/a n/a n/a
Operating Expenses
12.89M 13.98M 10.73M 23.63M 12.63M 18.69M 11.82M 19.48M 19.98M 33.89M 33.63M 56.65M 58.72M 54.29M 53.75M 43.02M 35.38M 23.4M
Interest Expense
1.58M 1.1M 2.59M 2.01M 2M 1.98M 1.98M 2M 590K 636K 745K 807K 331K n/a 538K n/a n/a 71K
Selling & Marketing Expenses
n/a n/a 993K n/a n/a -993K -1.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
12.9M 14.48M 23.54M 23.63M 18.41M 19.68M 12.86M 20.43M 19.98M 33.89M 33.63M 56.65M 58.72M 54.29M 53.75M 43.02M 35.38M 23.4M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -742K -605K -371K -609K -488K 1.06M -658K -159K -204K
Shares Outstanding (Basic)
6.6M 6.53M 6.53M 6.51M 6.5M 6.5M 6.5M 6.5M 6.5M 6.5M 6.49M 129.68M 129.37M 129.12M 128.95M 128.79M 128.74M 34.98M
Shares Outstanding (Diluted)
6.6M 6.53M 6.53M 6.51M 6.5M 6.5M 6.5M 6.5M 6.5M 6.5M 6.49M 129.68M 129.37M 129.12M 128.95M 128.79M 128.74M 34.98M
EPS (Basic)
-3.24 -4.32 -1.82 -3.54 -2.29 -3.74 -1.99 -10.37 -2.87 -8.66 -8.29 -0.43 -0.46 -0.42 -0.43 -0.33 -0.27 -0.66
EPS (Diluted)
-3.24 -4.32 -1.82 -3.54 -2.29 -3.74 -1.99 -10.37 -2.87 -8.66 -8.29 -0.43 -0.46 -0.42 -0.43 -0.33 -0.27 -0.66
EBITDA
-19.8M -30.56M -8.56M -20.11M -11.92M -21.58M -9.91M -64.48M -17.24M -54.38M -52.9M -53.38M -58.72M -52.81M -53.4M -42.9M -34.81M -22.89M
EBIT
-19.81M -27.1M -9.3M -21.01M -12.92M -22.57M -10.95M -65.43M -18.07M -56.68M -53.7M -55.79M -59.27M -54.6M -54.29M -43.66M -35.47M -23.4M
Depreciation & Amortization
12K 498K 741K 901K 1M 993K 1.04M 953K 835K 2.05M 807K 2.4M 979K 1.8M 893K 764K 656K 439K